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Abstract 
 
Background: Peripheral arterial disease (PAD) is a chronic, progressive disease with 
significant cardiovascular risk. Symptoms include pain in leg muscles on walking, 
relieved by rest (intermittent claudication). Treatment aims to maintain or improve 
quality of life (QoL) by minimising ischaemic symptoms and preventing progression to 
vascular occlusion.  Management strategies include exercise-based interventions.   
Methods: Research from 1989-2008 was systematically reviewed to identify the QoL 
impact of exercise-based interventions in patients with intermittent claudication.  
Results: Twenty-three studies were identified. Five were randomised controlled trials. 
Studies were summarised in terms of exercise interventions, QoL measures used and 
QoL findings.  The majority used a generic QoL instrument; most commonly the Short 
Form Health Survey (SF-36).  Eleven studies reported beneficial effects on the SF-36 
Physical Functioning scale. Some also reported positive effects on the scales of Bodily 
Pain, Role-Physical, Vitality, General Health and the Physical Component Score. In 
seven studies, a disease-specific measure was used. In six of these, both generic and 
disease-specific questionnaires were used. Disease-specific measures demonstrated 
greater improvements across a range of QoL domains.  
Conclusions: Greater use of disease-specific measures and an extended follow-up period 
may enable a more definitive picture to emerge regarding effects of exercise on QoL in 
intermittent claudication. 
Word Count: 200 
Keywords: intermittent claudication; peripheral arterial disease, exercise; quality of life
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Introduction 
Peripheral arterial disease (PAD) results in reduced blood flow to the extremities 
causing pain on exercise (intermittent claudication [IC]) which is relieved by rest.  As 
IC is a chronic, progressive disease with significant cardiovascular risk, it has a 
considerable impact on both functional status and quality of life (QoL) [1].  Factors 
impacting on the QoL of patients with PAD including fatigue, inactivity, social role 
limitations and depression, result in lower QoL for PAD patients than anticipated based 
on clinical status and disease severity [2].  
 
PAD exercise programmes have demonstrated significant increases in walking distances 
[3].  The effect of this increase on QoL is unclear [4-6].   A 2006 Cochrane review of 
supervised versus non-supervised exercise therapy [4] concluded that although 
supervised exercise resulted in significantly increased walking distance, the relevance of 
this for QoL required additional research.  A subsequent Cochrane review of exercise 
and IC concluded that the QoL results reported in six studies were variable and 
depended on the comparisons made [3].   
 
The purpose of this paper was to review all exercise-based interventions which assessed 
QoL of patients with IC as either a primary or secondary end-point.  This included a 
broader range of studies than in the previous Cochrane reviews i.e. all exercise (not just 
walking) studies, non-exercise control groups and non-randomised studies. 
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Methods  
The review involved systematic searches in the 20-year period 1989 to 2008 of the 
following databases: PubMed, PsycINFO, CINAHL and Cochrane Database of 
Systematic Reviews. The search terms used were ‘intermittent claudication’, ‘peripheral 
arterial disease’, ‘peripheral vascular disease’, ‘quality of life’, ‘exercise’, ‘walking’, 
‘physical activity’ and ‘rehabilitation’.  All terms were used as text words (i.e. words 
appearing in the title, abstract, key words and as subject headings).  Searches were 
limited to studies published in English.  Reference lists of retrieved articles were hand-
searched for additional references.  Papers were included if the study was designed as a 
clinical trial of an exercise-based intervention and QoL was specifically stated to be a 
primary or secondary outcome measure.  
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Results 
Following elimination of duplicates, searches yielded 356 results.  Of these, 24 journal 
articles met defined selection criteria. Authors confirmed that two publications reported 
on the same group of patients [7, 8].  Therefore the final number of studies was 23, of 
which five were randomised controlled trials [7-12]  (see Table 1).  
 
Table 1 here 
 
There was wide variety in the exercise intervention employed. Most studies used 
treadmill walking as the primary mode of exercise training [9, 11-22].  The most 
commonly reported duration of supervised exercise was twelve weeks [9, 12, 15, 17-21, 
23-25] (Table 1). A range of follow-up measurement times were reported:  two studies 
recording findings at six weeks [14, 26], eleven at twelve weeks [9, 12, 18-21, 23, 25, 
27-29], twelve at six months [7, 8, 11-14, 16, 18, 19, 21, 22, 24, 28]  and five at one 
year [10, 13, 14, 28, 30] (Table 1). 
 
Generic QoL Measures 
The SF-36 questionnaire (36 items in eight scales and two summary measures) is the 
recommended generic QoL measurement instrument in PAD [31].  It was the most 
frequently used generic QoL measure (16 studies) [7-9, 11, 13, 14, 16-19, 21, 22, 24, 
26-28, 30],  with two studies using the SF- 20 [12, 20] and two assessing general health 
status and global QoL using a numeric rating scale [15, 23].  One study used the EQ-5D 
[13], a 3-level, 5-dimensional instrument and one used the Profil der Lebensqualitat 
Chronisch Kranker (PLC) questionnaire [25] (Table 1).  The 40-item PLC, validated in 
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German, measures six dimensions of health. One study used several generic QoL 
questionnaires (Hospital Anxiety and Depression Scale, Mood Adjective Check List, 
General Health Rating Index- Current Health, Global indices: Quality of Life and 
Physical Condition, Life Satisfaction Scale, Sickness Impact Profile) [10].    Six studies 
used both a generic and a disease-specific questionnaire [10, 14, 15, 21, 23, 28] with 
one study using only a disease-specific questionnaire [29].  
 
Disease-Specific QoL Measures 
Of the seven studies that used disease-specific measures [10, 14, 15, 21, 23, 28, 29] 
(Table 1), the Peripheral Arterial Occlusive Disease 86 (PAVK-86) questionnaire was 
used in three [15, 21, 23] . The PAVK-86, an 86-item questionnaire validated in 
German, covers seven QoL dimensions [32].  The Intermittent Claudication 
questionnaire, a 16-item measure with a single health dimension score [33], was used in 
2 studies [14, 28].  One study [29] used the VascuQoL- a five domain, 25-item 
questionnaire developed for patients with a wide range of chronic lower limb ischaemia 
[34]. One study [10] used the Sickness Impact Profile - Intermittent Claudication scale 
(a twelve-item IC-specific scale [35]) and a study-specific Symptoms and Complaints 
Scale .  
 
Generic Assessment of QoL following Participation in Supervised Exercise 
Programmes 
SF-36:  Eleven of 16 studies [8, 9, 13, 16, 17, 19, 21, 22, 24, 26, 28] reported an 
improvement in SF-36 Physical Functioning following participation in supervised 
exercise. Improvements in Bodily Pain (6 studies) [9, 16, 17, 19, 21, 22],  Role- 
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Physical (5 studies) [9, 17, 21, 24, 26], Physical Component Score (3 studies) [7, 17, 
19] and Vitality and General Health (one study) [9] were also reported.     
 
SF- 20: In the 2 studies using the SF-20 , there were improvements in the Physical 
Functioning domain following supervised treadmill exercise [12, 20] with an increase in 
the Well-being domain in the strength training group study only [12].  
 
Profil der Lebensqualitat Chronisch Kranker (PLC): Four dimensions (Physical 
Capacity, Psychological Functioning, Positive Mood, Social Functioning) improved and 
Negative Mood decreased after completion of a twelve-week exercise programme [25] . 
 
All SF-36, SF-20 and PLC changes were associated with increases in walking ability.  
 
Sickness Impact Profile (SIP): A significant improvement was noted only in the 
Recreation and Pastimes category (of eleven categories assessed) at one-year follow-up 
assessment [10]. 
 
 
Disease-specific Assessment of QoL following Participation in Supervised Exercise 
Programmes 
Disease-specific questionnaires demonstrated improvements across a range of domains. 
However, the diversity of questionnaires used, the variation in exercise regimes and 
inclusion criteria limit robust interpretation of study findings.  Three studies used both 
the PAVK-86 and a generic QoL measure [15, 21, 23].  In one, both the SF-36 and 
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PAVK-86 detected improvements in pain and functional status but the PAVK-86 also 
detected improvement in the anxiety domain [21]. In the second study, improvements in 
all PAVK-86 domains (except general complaints) were reported. However, no changes 
were noted with the global generic measure [23]. In the third study, the Pain and 
Functional Status domains of the PAVK- 86 significantly correlated with walking 
distance but the global generic measure showed no correlation.  
In the two studies using both the ICQ and SF-36 measures, improvements in ICQ scores 
were reported with no change in SF-36 domains in one study [14] and a borderline 
increase in physical functioning domain in the other [28].  In a study administering a 
battery of tests, only a change in the SIP Recreation and Pastimes category  and a global 
rating for physical condition were noted [10], with no change in the SIPIC scale.  
QoL improvements were associated with increases in walking distances in all studies 
except one [10].  
 
QoL Assessment following Participation in Unsupervised Exercise Programmes 
Varying definitions of unsupervised home exercise programmes confounded the 
interpretation of QoL findings. Unsupervised exercise programmes comprised differing 
levels of support, use of specific patient instructions, diaries and logbooks, follow-up 
phone calls and weekly lectures.  None of the seven studies [18-21, 27-29] of 
unsupervised exercise had a control group. Unsupervised exercise had a minimal effect 
on QoL as measured by SF-36.  Walking distances were unchanged or demonstrated 
smaller improvements than with supervised exercise.  However some QoL improvement 
was noted with disease-specific measures. In the two studies using the SF-36 and a 
disease-specific questionnaire, improvement in ICQ score with no change in any SF-36 
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domains was noted [28] and an increase in  Pain and Anxiety in the PAVK–86 but no 
change in the SF-36 Bodily Pain domain [21].  Changes in all VascuQol domains 
(except social functioning) were also noted [29].  
 
Discussion 
The majority of changes were reported from scores obtained immediately following 
completion of an exercise programme.  However, the time between initial and 
subsequent assessment is an important factor. It has been postulated that improvements 
in QoL and mental health may lag behind improvements in ambulatory function [9, 11] 
and this may explain the limited change in SF-36 Role- Emotional and Mental Health 
domains.  Patients in exercise programmes may also underestimate QoL because 
improvement occurs slowly and less noticeably than with  interventions, such as 
revascularisation [13].  The prevalence of concomitant chronic illnesses such as 
diabetes, hypertension and coronary artery disease is very common in PAD and can 
impact on QoL [36, 37].  Of the 23 studies reviewed, only seven [7-12, 24, 26] included 
a non-exercise control group. Two of these were non-randomised [24, 26]. This also 
confounds the interpretation of QoL assessment findings. 
In five of the six studies reporting generic and disease-specific QoL findings, generic 
measures did detect additional QoL changes.  Disease-specific measures were however 
more responsive to QoL improvements and detected changes across a range of domains 
following both supervised and home-based exercise.  However a variety of instruments 
was used. Although the VascuQoL instrument has been recommended [38],  it has not 
been evaluated against the ICQ for QoL effects of exercise interventions.   The PAVK-
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86 takes 20 minutes to complete and may prove too time-consuming for many practical 
applications.  
The findings of studies included in this review support the positive impact of exercise 
on physically-related components of QoL for IC.  QoL improvements were associated 
with gains in exercise performance evidenced by increases in claudication times and 
distances which were greater following supervised than unsupervised exercise.  These 
improvements were maintained in those patients who continued to exercise on a regular 
basis following discontinuation of the formal exercise programme [17, 28].   Greater 
improvements in exercise performance and QOL following unsupervised exercise 
programmes correlated with self-reported exercise adherence  [29].    
Social support may be a significant contributor to QoL in patients with IC. The peer 
support of supervised exercise participation may prevent deterioration in QoL 
associated with conservative therapy [24]. 
A more ambivalent picture emerged regarding effects on the more psychological 
dimensions assessed.  Impairment in these aspects has been established in IC patients 
[23, 39].  Overall however, the capacity to draw firm conclusions was severely 
hampered by the plethora of instruments used, and timeframes assessed.  PAD and IC 
are increasing in prevalence and will need intensive interventions – both 
pharmacological and exercise based – to minimise their personal and societal impact. 
The role of exercise in the prevention and progression of vascular disease has been 
emphasised [40].   Better use of QOL instruments is needed to document differential 
benefits of particular programmes; evidence is increasingly needed to justify 
programme funding. As in other areas of cardiovascular assessment, a programme of 
psychometric evaluation of instruments is needed to inform the international clinical 
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and research community about the best instruments to use [41, 42]. Thus standardised 
evaluation and use of disease-specific QoL measures, with longer and more comparable 
follow-up periods may enable a more definitive picture to emerge regarding the effects 
of exercise on QoL and the disease-specific instrument of choice.  
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Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
         1 
Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Spronk  
2008 
[16] 
 
 
Exercise (75)  
 
 
 
 
 
Endovascular 
revascularisatio
n 
(76) 
 
Supervised 
treadmill walking 
 
30 minutes x 
2/week x 24 
weeks 
 
  
Baseline, 6 
months, 1 
year 
ICD  
Post exercise mean 
score improvement 
(6 months): 899 
(743, 1054) 
(1 year): 943 (786, 
1099) 
 
 
ACD  
Post exercise mean 
score improvement  
(6 months): 1138 
(1006, 1270) 
(1 year): 1034 
(896, 1170) 
EQ-5D  
Rating scale 
 
 
SF-36  
Physical 
Functioning 
domain only 
Mean score improvement in 6 months 
(0.09) and 12 months (0.07) EQ5D, 
rating scale and SF-36 Physical 
Functioning in both groups. Difference 
between groups not statistically 
significant. Increase in EQ-5D rating 
scale and SF-36 Physical Functioning in 
exercise group from 6 to 12 months. 
Non-significant decrease in all QoL 
measures from 6 to 12 months in 
revascularisaton group 
Prospective randomised clinical 
trial 
 
Postulated that exercise group 
may have underestimated QoL 
initially as improvements occur 
slowly with exercise 
 
No control group 
11 patients in exercise group 
underwent surgical intervention 
or revascularisation. 
Study designed to demonstrate 
clinically relevant differences 
rather than QOL 
Patients excluded on anatomical 
basis who may have been good 
candidates for exercise 
Compliance: N/A 
Roberts et 
al 2008 
[31] 
Exercise (47) Unsupervised 
home-based 
walking exercise 
programme 
supported by 
weekly telephone 
advice/exercise 
diaries 
 
1 hour 
walking/day  x 
12 weeks 
Baseline and 
12 weeks 
 ICD 
N/A 
 
ACD 
Pre: 126  
Post 222 
(p<0.001) 
76% increase  
VascuQoL 
(disease-specific, 5 
domains) 
 (Activities, 
Symptoms, Pain, 
Emotional Effects 
and Social 
Functioning) 
Scores increased significantly (p<0.0001) 
in all domains except Social Functioning 
 
% increase 
Total score 22.4% 
Activities 26.3% 
Symptoms 23% 
Pain 41.6% 
Emotional Effects 20% 
  
No control group and remote 
type of supervision 
 
VascuQoL is not entirely 
specific to claudicant patients.  
It can be used across a range of 
chronic lower limb ischaemia  
Median compliance 5 
hours/week  
Exercise compliance correlated 
with % change in max walk 
distance and total VascuQol 
score 
Jeger et al 
2008 
[27] 
Exercise (99)  
 
Fontaine Stage 
1 (27) 
 
Supervised 
cardiac 
rehabilitation 
programme- 
aerobic, strength 
Baseline and 
12 weeks 
ICD/ACD 
N/A 
 
% target workload 
on cycle ergometer 
 PLC  
(generic,  6 
dimensions)  
 (Physical 
Capacity, 
Four dimensions (Physical Capacity, 
Psychological Functioning, Positive 
Mood, Social Functioning) improved. 
Negative Mood decreased.  Tendency 
towards decrease in Social Well-being 
Population of coronary artery 
disease patients with PAD 
participating in a formal cardiac 
rehabilitation programme.   
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life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
Fontaine Stage 
II    (69)  
 
Fontaine  Stage 
III  (3) 
 
 
Total 1508 
patients 
and coordination 
training 
 
12 weeks  
Weeks 1-4: 
Mixed  physical 
activities 1-2 
hours daily 
Weeks 5-12: 
Mixed physical 
activities 1-2 
hours x 2 
days/week  
stress test 
Pre: 69% +/-17 
Post: 82% +/-25 
Psychological 
Functioning, 
Positive Mood, 
Negative Mood, 
Social 
Functioning, 
Social Well-being).  
Validated for 
German speaking 
population 
% increase 
Physical Capacity 25% 
Psychological Functioning 15% 
Positive Mood 12.5% 
Negative Mood 17% decrease 
Social Functioning 15% 
Patients with PAD had higher 
dropout rate (18% 
discontinuation of exercise, 18 
out of 99 pts).  
 
No control group 
 
 
Keo et al 
2008 
[17] 
Exercise (36) Supervised 
walking (floor 
and treadmill), 
tip toe standing, 
cycle ergometer. 
 
12 weeks 
Weeks 1-6: 1 
hour exercise x 
2/week 
Weeks 7-12: 1 
hour exercise x 
1/week 
 
Baseline,  
Follow - up at 
39+/- 20 
months post 
exercise 
programme 
ICD* 
Pre: 114 +/-100 
12 weeks: 235 +/-
247 
F/Up (39+/-20 
months):  197 +/-
254 
 
ACD* 
Pre: 297 +/-273 
12 weeks: 474 +/-
359 
F/Up (39+/-20 
months):  390 +/-
324 
 
 
*mean (SD) 
PAVK-86 
(disease-specific, 7 
domains). 
(Pain, General  
Complaints, 
Functional Status, 
Anxiety, Mood, 
Social Life and 
Treatment 
Expectations) 
Validated for 
German speaking 
population 
 
General health 
status and global 
QoL assessed 
using numeric 
rating scale 
 
Pain and Functional Status correlated 
with walking distance. 
General Complaints, Anxiety,  Mood, 
Social Life and Treatment Expectations 
did not show significant correlation with 
walking capacity 
 
 
Global QoL and general health status did 
not show significant correlation with 
walking capacity 
 
No specific data provided 
No control group 
 
Non-randomised 
 
Recruited retrospectively 
following programme 
completion 
Compliance N/A 
Lee et al 
2007 
[26] 
Control (37)  
 
 
 
 
 
 
 
Baseline and 
6 months 
following 
treatment 
ICD* 
Pre exercise: 58.5 
(39.2-112.7) 
Post exercise: 
SF-36  
Global index score 
and 8 QoL 
domains 
Control Group  Deterioration in 7 of 8 
domains (except Bodily Pain) and SF-36 
index with effect size > -0.5 for Role- 
Emotional and Physical Functioning.  
Non- randomised trial 
Patients recruited sequentially 
and divided into those recruited 
before and after the 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
 
Exercise (33)  
 
 
Supervised 
Stepping, heel 
raise, single leg 
press, cycle, knee 
extension, elbow 
flexion 
 
12 weeks 
1 hour x 3/week 
107.5 (52.5-153.8) 
ACD* 
Pre exercise: 117.6 
(73.5-205.8) 
Post exercise: 300 
(143.8-300) 
 
 
* median (IQR) 
 Exercise Group 
No significant changes in domains or 
index.  Positive effect sizes for SF36 
index and 2 domains (Physical 
Functioning and Role- Physical). 
Negative effect sizes for Bodily Pain and 
General Health  
 
Physical Functioning* 
Pre: 45 (25-62.5) 
Post 50 (35 -67.5) 
Role – Physical*  
Pre: 0  (0-75) 
Post: 25 (0-87.5) 
SF 36 Index* 
Pre: 0.600 (0.570-0.645) 
Post: 0.630 (0.570-0.650) 
Bodily pain* 
Pre: 52 (42-69) 
Post: 42 (31-52) 
General health* 
Pre: 65 (52-72) 
Post: 60 (47-52.5) 
Intergroup  
Vitality significantly improved (p<0.01) 
following exercise compared with control 
group. 
Intergroup effect sizes >0.5 for SF-36 
index and domains of Physical Function, 
Role-Physical and Role-Emotional   
* median (IQR) 
establishment of a supervised 
exercise programme 
 
Compliance N/A 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Serracino
-Inglott et 
al 2007 
[32] 
165 Supervised 
exercise  
(Scottish 
Physiotherapy 
Amputee 
Research Group 
guidelines) 
1/week for 12 
weeks and 
follow-up x 
1/month x 1 year  
 
Baseline, 6 
months and 1 
year 
ICD* 
Pre: 50 (6-128) 
Post 94 (24-409) 
ACD*  
Pre: 67 (17-196) 
Post 122 (43-409) 
 
* median (IQR) 
 
SF-36 
(no detail 
regarding domains 
measured) 
 
QoL increased significantly (p<0.0001) 
from a median of 78 (range 55-110) to 99 
(range 71-154) 
 
No detail provided regarding median 
score calculations 
No control group 
Only reported on those who had 
completed programme 
 
Imfeld et 
al 2006 
[23] 
Group 1  
Exercise (18) 
 
 
 
 
 
Group 2 
Exercise + 
clopidogrel (17) 
 
 
 
 
 
Group 3 
Home based 
training (20) 
Supervised 
treadmill walking 
1 hour x 3/week 
x 12 weeks 
 
 
 
Supervised 
treadmill walking 
1 hour x 3/week 
x 12 weeks 
 
 
 
 
Unsupervised 
(phone call x 
1/week and 
logbook) 
Walking at least 
1 hour/day x 12 
weeks 
Baseline, 12 
weeks and 24 
weeks 
ICD* 
Pre 
Group 1: 175 +/-
136 
Group 2: 159 +/-97 
Group 3: 159 +/-78 
 
ACD* 
Pre 
Group 1: 492 +/-
259 
Group 2: 477 +/-
213 
Group 3: 530 +/-
232 
 
ICD (% increase) 
Post 
Group 1: 164 
Group 2: 201 
Group 3: 44 
 
ACD (% increase) 
Post 
Group 1: 83 
SF-36 (General 
health domain not 
reported)  
 
 PAVK – 86  
(5 domains 
assessed, excluded 
mood and social 
life) 
SF 36 
Within Groups 
Bodily Pain improved in Groups 1 and 2 
but not for home training at 12 weeks 
 
Physical Functioning Significant  
increase in all 3 groups (group 1, 
p=0.029; group 2, p= 0.003; group 3, 
p=0.012) at 12 weeks, maintained at 24 
weeks 
 
Role- Physical  
Limited by ceiling effect. Significant 
increase in Group 2 (p=0.025) at 12 
weeks.  Significant increase in Group 3 
(p=0.046) at 24 weeks 
 
No changes in Mental Health, Vitality, 
Social Function, Role - Emotional in any 
group 
 
Between groups 
Bodily pain 
At 12 weeks improvement in Group 2 
significantly better than Group 3 
Non-randomised 
 
No control group 
 
All 3 groups showed similar 
improvements in Physical 
Functioning (SF-36), Pain and 
Anxiety (PAVK). No  significant 
improvements or differences in 
other QoL domains between 
training modalities 
 
Compliance based on log 
entries and phone interviews 
Group 1 
21% (4patients) missed < 6 
sessions 
Group 2 
36.8% (7 patients) missed < 6 
sessions 
Group 3 
23.8% (5 patients) missed >7 < 
14 sessions 
33.3% (7 patients) missed < 7 
sessions 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Group 2: 131 
Group 3: 5 
 
*mean (SD) 
(p=0.018). 
At 24 weeks, Group 2 better than Groups 
1 and 3, no difference between Groups 1 
and 3 
 
Physical Functioning 
Group 3 significantly lower (p=0.046) 
than Groups 1 and 2 (p=0.022) 
At 24 weeks no significant differences 
between 3 study groups 
 
PAVK-86 
Within groups 
Pain and anxiety 
Significant improvement in all 3 groups 
(p<0.02) at 12 weeks. 
Functional status 
Improvement at 12 weeks for Groups 1 
and 3. 
Significant improvement at 24 weeks 
only in Group 2 (p=0.033) 
 
Between groups 
No significant differences in any of study 
phases.  
 
Kakkos et 
al 2005 
[11] 
Group 1 
Unsupervised/ 
Exercise advice 
(9) 
 
Group 2 
Exercise (12) 
 
Group 3 
 
 
 
 
Supervised  
treadmill walking 
3/week x 6 
months 
 
 
IPC (home) 
Baseline, 6 
weeks, 6 
months, 1 
year 
ICD* 
Pre 
Group 1: 70 (22.5) 
Group 2: 60 
(26.25) 
 
6weeks 
Group 1:80 (45) 
Group 2: 80 (35) 
 
6 months 
SF-36 (all 8 
domains and 2 
component scores) 
 
 ICQ 
(disease-specific) 
SF-36 
Significant improvement in General 
Health in IPC group at 1 year   
 
ICQ 
ICQ scores at 6 months in IPC and 
supervised exercise groups reduced by 
33% and 17% respectively (note: a higher 
score indicates poorer QoL) but 
significant in IPC group only (p=0.037). 
No change in unsupervised exercise 
Discontinued intervention  
Exercise (6) 
IPC (2) 
 
Analysed at 1 year 
Unsupervised /control (8) 
Exercise (6) 
IPC (9) 
 
Patients with ACD < 50 metres 
or >300metres were excluded 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
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Intervention 
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Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Intermittent 
pneumatic foot 
and calf 
compression 
(IPC) (13) 
Daily x 3 hours x 
6 months 
Group 1: 70 (35) 
Group 2: 70 (45) 
 
12 months: 
Group 1: 80 (55) 
Group 2: 90 (50) 
 
 
ACD* 
Pre 
Group 1: 135 
(87.5) 
Group 2: 145 
(108.75) 
 
6 weeks: 
Group 1: 130 (130) 
Group 2: 235 
(142.5) 
 
6 months: 
Group 1: 140 (60) 
Group 2: 220 
(282.5) 
 
12 months: 
Group 1: 135 
(57.5) 
Group 2: 270 (700) 
 
*median (IQR) 
group 
 
 
Small numbers due to poor 
compliance in active groups 
 
Exercise compliance: 
Attendance at supervised 
exercise class ranged from 12.8 
– 100% (median 60.3%) 
Gardner 
et al 2005 
[24] 
Group 1 
Low intensity 
(40% maximal 
exercise 
capacity) 
exercise (31) 
Supervised 
treadmill walking 
3 days/week x 6 
months 
Baseline and 
6 months  
ICD* 
Pre 
Group 1:163 (123) 
Group 2: 186 (143) 
 
ACD* 
SF-36 (8 domains) Significant improvement (p<0.05) in 
Physical Functioning and Bodily Pain 
after exercise, similar in both groups.  
Neither group had significant change in 
other health domains 
 
No control group 
Compliance similar in both 
groups 
LI: 80% attendance (+/- 16%) 
HI: 74% attendance (+/-18%) 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
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86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
Group 2 
High intensity  
(80% maximal 
exercise 
capacity) 
exercise (33) 
 
Pre 
Group 1: 418 (228) 
Group 2: 430 (222) 
 
ICD* 
Post 
Group 1: 341 (218) 
Group 2: 388 (236) 
 
ACD* 
Post 
Group 1: 674 (293) 
Group 2: 700 (281) 
 
*mean (SD) 
Physical Functioning* 
Group 1: 46 (19) pre; 58 (23) post 
(26% increase) 
Group 2: 49 (24) pre; 59 (21) post 
(20%  increase) 
 
Bodily Pain* 
Group 1: 48 (19) pre; 61 (24) post 
(27% increase)  
Group 2: 53 (19)pre; 64 (25) post  
(21% increase) 
 
 
*mean (SD) 
Collins et 
al 2005, 
2003 
[9,10] 
Polestriding   
(27) 
 
Control  
(25) 
Supervised 
Polestriding 
exercise 
3 days/week x 24 
weeks 
 
Baseline and 
6 months 
ICD/ACD 
N/A 
 
Polestriding group 
Increase in 
endurance on 
treadmill test 
(minutes)*: 
Pre: 10.3 (+/4.1) 
Post 15.1 (+/-4.5) 
(47% increase) 
 
*mean (SD) 
SF-36 Physical 
Component (PCS) 
and Mental 
Component (MCS) 
scores (2005) 
 
 8 individual 
domains (2003) 
Significant change (p=0.03) in Physical 
Component Score for Polestriding group 
compared with control group. 
No change in Mental Component Score 
between groups.  
Effect size changes in Physical 
Component Score indicated a moderate -
large improvement in Polestriding group 
(effect size= 0.70) and no change in 
control group (effect size = 0.04). 
Negligible effect size changes for Mental 
Component Score of Polestriding (effect 
size = 0.06) and control (effect size= 
0.11) 
Significant Polestriding  effect at 6 
months on Physical Functioning  scale 
only (p=0.003) 
Compliance: 88% +/- 23% 
Control group seen biweekly 
for measurement of 
ankle/brachial index, weight, 
heart rate, blood pressure, 
physical activity record and 
drug compliance for first 3 
months and monthly thereafter 
 
 
 
Cheetham 
et al 2004 
[30] 
Group 1 
Exercise advice 
alone (30) 
 
Group 2 
 
 
 
Group 2 
Supervised  
Baseline, 3 
months, 6 
months, 9 
months, 1 
year 
ICD 
N/A 
 
ACD*  
Pre:  
SF-36  
 (8 domains) 
 
CCCQ 
(now ICQ) 
SF 36 
No significant improvement in any 
domains at 6 months. 
No significant differences in 7 of 8 
domains over 12 month period.  In 
No control group 
All patients given verbal and 
written exercise advice 
Highly significant correlation 
between self- report compliance 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
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Intervention 
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Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Exercise advice 
+ weekly 
exercise + 
motivation class 
(29) 
walking circuit, 7 
x 2 minute 
exercise stations  
1/week x 6 
months 
Group 1: 103 
Group 2: 132 
 
3 months: 
Group 1: 119 (19% 
increase) 
Group 2: 220 (67% 
increase) 
 
6 months: 
Group 1: 174 (69% 
increase) 
Group 2: 302 
(129% increase) 
 
* median 
Physical Functioning domain, borderline 
significant improvement in exercise class 
group 
No specific data provided 
 
CCCQ 
Improvement in scores in both groups but 
significantly better improvement 
(p<0.05) in exercise group (43%) than 
advice group (16%) at 9 months 
 
to walking  advice and drop in 
CCCQ score (improved 
symptoms) and claiming to 
walk >3 times/week 
More than twice as many in 
exercise class claimed to be 
walking > 3 times/week 
compared to advice group 
Gardner 
et al 2004 
[18] 
 
Group 1 
Smokers (39) 
 
Group 2 
Non-smokers 
(46) 
Supervised 
treadmill walking 
 
3/week x 6 
months 
Baseline and 
6 months 
ICD* 
Group 1 
Pre: 160 (16)  
Post: 351(39) 
(119% increase) 
Group 2: 
Pre: 199 (21) 
Post: 393 (41) 
(97.5% increase) 
 
ACD* 
Group 1 
Pre: 365 (32) 
Post: 665 (51) 
(82% increase) 
Group 2: 
Pre: 430 (31) 
Post: 684 (49) 
(59% increase) 
   
 *mean (SEM) 
SF-36 (8 domains) Smokers had significantly lower (p<0.5) 
scores on Bodily Pain, General Health, 
Mental Health and Vitality than non-
smokers at baseline.  Both groups had 
significant (p<0.5) and similar 
improvement in Physical Functioning 
and Bodily Pain following exercise.  
None of the other health domains 
changed following exercise in either 
group.  
 
Physical Functioning* 
Group 1: 48 (6) pre;  59 (6) post 
(22.9 % increase) 
Group 2: 51 (5) pre;  61(4) post 
(19.6 % increase) 
 
Bodily Pain* 
Group 1: 49 (5) pre;  62 (7) post 
(26.5% increase) 
Group 2: 60 (4) pre;  69 (5) post 
Smokers more limited by 
intermittent claudication at 
baseline 
 
No control group 
 
Compliance with exercise 
programme: approximately 
75% in both groups. 
Smokers: 73% +/- 4% 
Non-smokers: 77 +/- 4% 
 
 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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changes following 
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QoL measure                     QoL findings 
 
Additional Comments 
(15% increase) 
   
 *mean (SEM) 
Menard et 
al 2004 
[19] 
34 who 
completed 
exercise 
programme at 
least 12 months 
prior to study. 
At follow- up, 
defined as 
exercisers (15),  
sedentary (19) 
 
Supervised 
treadmill 
walking, arm and 
leg ergometry, 
light free weight 
training, 
flexibility 
exercises 
 
3/week x 12 
weeks 
Baseline and 
follow up at 
20-80 months 
(mean 48.2 
+/- 13.7 
months) 
ICD/ACD 
Specific values not 
provided but 
reported 121% 
increase in 
claudication pain 
time and 109% 
increase in 
maximum walking 
time at long-term 
follow-up in 
exercise group 
with values 
returned to 
baseline in 
sedentary group 
SF-36 (8 domains 
and 2 component 
scores) 
Those who were continuing to exercise at 
time of follow-up had significantly 
higher scores in Physical Functioning, 
Role- Physical, Bodily Pain, Physical 
Component Score 
 
Physical Functioning* 
Exercise: 43.3 +/-8.2 
Sedentary: 34.2 +/-7.8 
 
Role- Physical* 
Exercise: 41.2 +/-7.7 
Sedentary: 32.8 +/-9.2 
 
BodilyPain* 
Exercise: 46.9 +/-8.8 
Sedentary: 38.9 +/-7.1 
 
Physical Composite Score* 
Exercise: 43.5 +/-6.5 
Sedentary: 34.0 +/-5.8 
 
No differences between groups in 
General Health, Vitality, Social 
Functioning, Role-Emotional, Mental 
Health or Mental Component scores 
 
*mean (SD) 
Follow-up of patients who had 
completed exercise programme 
 
No control group 
 
Those who continued to 
exercise  (60 minutes or 
>/week) had significantly 
increased Physical Functioning, 
Role-Physical , Bodily Pain and 
Physical Component Score 
compared with sedentary group 
Exercise group had increased  
IC and AC times at 1 year  
 
 
 
Tsai et al 
2002 
[12] 
Exercise (32) 
 
 
 
 
 
Supervised 
treadmill walking 
 
3/week x 12 
weeks 
 
Baseline and 
12 weeks 
ICD/ACD 
NA 
 
IC Time 
Exercise group 
88% increase  
SF-36 (8 domains) Exercise group: Significantly higher 
scores on 5 subscales (Physical 
Functioning, Role –Physical, Bodily 
Pain, General Health, Vitality) following 
exercise programme. Improvements in 
physical health component more 
27 patients in exercise group 
and 26 patients in control group 
completed study 
 
Compliance: 82 +/-16% of 
sessions 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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participantsa 
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Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
Control (32) 
 
Usual care 
control 
 
Control group 
10% increase 
 
AC Time 
Exercise group 
36% increase  
 
Control group 
6% increase 
 
pronounced than mental health 
component.    
 
Physical Functioning* (p<0.001) 
Pre: 39.5 +/-0.1 Post: 58 +/-10.6 
47% increase 
Role Physical* (p<0.04) 
Pre:  22.5 +/-30  Post 62.5 +/-31.7 
178% increase 
Bodily Pain* (p<0.03) 
Pre: 64.8 +/-15.9  Post 81.5 +/-18.4 
26% increase 
General Health* (p<0.02) 
Pre: 54 +/-13.4  Post: 64.8 +/-0.1 
20% increase 
 
Vitality*( p<0.02) 
Pre: 54.5 +/- 15.2 Post: 70 +/-12.9 
28% increase 
 
Correlation of Physical Functioning 
improvement with increased AC Time: 
r=0.66 
Correlation of Bodily Pain improvement 
with increased AC Time: r=0.65 
 
No changes in scores in Control group.  
 
*mean (SD) 
22 patients (out of 27) attended 
at least 80% of sessions 
 
 
Garten-
mann 
2002 
[25] 
Exercise  (31) Supervised 
walking, cycle 
ergometer 
 
Weeks 1-6:  
1hour x 2/week 
 
Weeks 7-12: 
Baseline and 
12 weeks 
ICD* 
Pre: 129 +/- 19 
6 weeks: 230 +/-45 
12 weeks: 364 +/-
53 
(182 +/- 44  
increase from 
baseline) 
PAVK-86 
(disease-specific, 7 
domains ). 
(Pain, General  
Complaints, 
Functional Status, 
Anxiety, Mood, 
Social Life and 
All dimensions (except subscale General 
Complaints) improved, largest effect 
sizes for Pain (0.56), Mood (0.45) and 
Functional Status (0.42) 
 
Significant correlations: 
ICD and anxiety r=0.46 
ACD and mood r=0.45 
Patients were unsuitable for 
catheter intervention  (26) or 
unwilling to undergo invasive 
treatment (3) 
 
No control group 
 
Compliance: N/A 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
1hour/week  
ACD* 
Pre: 311 +/- 28 
6 weeks: 453 +/-60  
12 weeks: 546 +/-
63 
(76 +/-36 increase 
from baseline) 
 
*mean (SEM) 
Treatment 
Expectations) 
 
General health 
status and global 
QoL assessed 
using numeric 
rating scale 
Walking distance during training with 
pain r=0.53 
 
No significant changes for global QoL 
and general health status scales 
Taft et al 
2001  
[13] 
Control (89) 
 
Exercise (88) 
 
 
 
 
 
 
 
 
Invasive therapy 
(87) 
 
 
Supervised 
walking  
Months 1-6 
3 x 30 minutes 
walking/week  
 
Months 7-12 
2 x 30 minutes 
walking//week 
Baseline and 
1 year 
Exercise Group 
 
ICD* 
N/A 
 
ACD* 
Pre: 258 +/-142 
Post: 247 +/- 111 
 
*mean (SD) 
Sickness Impact 
Profile (omitted 
Communication 
Category) 
Life Satisfaction 
scale (LS) 
Global Indices: 
Quality of Life and 
Physical condition 
 
General Health 
Rating Index -, 
Current Health 
(GHRI-CH) 
 
 
Hospital Anxiety 
and Depression 
scale (HAD) 
 
Mood Adjective 
Check List 
(MACL) 
 
Sickness Impact 
Profile IC scale 
 
Exercise group 
Significant improvement in SIP 
Recreation and Pastimes category 
(p<0.05). Body Care and movement 
category deteriorated (p<0.01 ) 
 
No significant changes in SIP Emotional 
behaviour, Social interaction, Alertness 
behaviour or Psychosocial dimension in 
any groups. 
 
Improvement in global rating for physical 
condition  
 
 
No significant difference in LS Global 
Indices, Health Rating Index, HAD, 
MACL  
 
 
Significant improvement in SIPIC scale 
for invasive therapy group only (p<0.05)  
 
 
Poor compliance in exercise 
group.  Only 49% (43 out of 48) 
of patients completed 6 months 
of training 
Included pts with severe 
claudication: Ankle/brachial 
index < 0.6 
 
Control group: general advice 
only 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Symptoms and 
Complaints Scale 
(study-specific 
scale) 
 
Gardner 
et al 2001 
[14] 
Exercise (31) 
 
 
 
 
 
 
Control (30) 
Supervised 
treadmill walking 
 
3 days/week x 6 
months 
 
 
Usual care 
control 
Baseline and 
6 months 
ICD* 
Exercise  
Pre: 172 +/-26 
Post: 402 +/- 56 
(134% increase) 
 
 
ACD* 
Exercise 
Pre: 396 +/-43 
Post: 702 +/-57 
(77% increase) 
 
*mean (SEM) 
 
SF-36 (8 domains 
and 2 component 
scores) 
Physical Component and Mental 
Component scores were similar between 
2 groups and did not change.  No 
analyses performed on subscales 
 
Prospective randomised 
controlled trial 
28 patients in exercise group 
and 24 patients in control group 
completed the study 
 
Mean compliance: 73% (+/-
28%) 
19 (out of 28) pts attending at 
least 70% 
 
 
Savage et 
al 2001 
[20] 
 
Group 1 
Supervised 
exercise (11) 
 
 
 
 
 
 
 
 
 
Group 2 
Home-based 
exercise  (10) 
Group 1 
Supervised 
exercise  
Supervised 
treadmill walking 
3/week x 12 
weeks supervised 
+ 12 weeks home 
–based 
 
 
 
Group 2 
Home-based 
exercise 
Walking x 
3/week x 24 
Baseline, 12 
weeks, 24 
weeks 
ICD* 
Group 1 
Pre: 241.2  +/- 
188.2 
12 weeks: 456.9 
+/-317.2 
(90% increase) 
6 months: 483.8 
+/- 317.2 
(101% increase 
from baseline) 
 
 
Group 2 
Pre:182.8 +/-150.5 
12 weeks: 225.8 
+/- 150.5 
SF-36 (8 domains) No significant changes in any of the 
health domains in either group at 12 or 24 
weeks. 
Responses of all domains were similar 
between groups 
No control group 
 
Compliance N/A 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
weeks and  
contacted once a 
month by phone 
 
(24% increase) 
6 months: 263.4 
+/-155.9 
(44% increase 
from baseline) 
 
ACD* 
Group 1 
Pre: 521.5 +/-263.4 
12 weeks: 833.3 
+/-376.3 
(60% increase) 
24 weeks: 741.9 
+/- 365.6 
(42% increase 
from baseline) 
 
Group 2 
Home based 
exercise  
Pre:532.2 +/-263.5 
12 weeks: 736.5 
+/-  290.3 
(38% increase) 
24 weeks: 715 +/-
394.4 
(34% increase 
from baseline) 
 
*mean (SD) 
Walker et 
al 2000 
[28] 
Group 1 
Upper limb 
training (26) 
 
Group 2 
Lower limb 
training (26) 
Group 1 
Supervised upper 
limb cycle 
ergometry 
 
Group 2 
Supervised lower 
Baseline and 
6 weeks 
ICD/ACD 
Specific values not 
provided post 
training. 
ICD increased by 
122% (Group 1) 
and by 93% 
SF-36 (8 domains) Significant improvement in Physical 
Functioning (upper limb training p=0.03; 
lower limb training p=0.04) and Role – 
Physical (upper limb training p=0.01; 
lower limb training p=0.02)  
Specific values not reported. 
 
Randomised to upper limb and 
lower limb training groups. 
Additional untrained group 
recruited on ad hoc basis.  
 
Compliance:  
Upper limb group:98% 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
Group 3 
Untrained group 
(15) 
limb cycle 
ergometry 
2/week x 6 weeks 
 
Group 3 
Lifestyle advice 
(Group 2).  
ACD increased by 
47% (Group 1) and 
by 50% (Group 2) 
 
 
No change in 
ICD/ACD in 
Group 3.  
No significant changes in other domains.  
 
No significant changes in any of QoL 
domains in untrained group 
 
attendance  
Lower limb group: 94% 
attendance  
Patterson 
et al 1997 
[21] 
Group 1 
Supervised 
exercise (27) 
 
 
 
 
 
 
 
 
Group 2 
Home exercise 
(28) 
Group 1 
Treadmill 
walking, arm and 
leg ergometry, 
cycling 
(supervised) 
 
3 x 1 hours/week 
x 12 weeks 
 
 
Group 2 
Unsupervised 
Weekly exercise 
instruction (walk 
minimum 3 
/week x 20-40 
minutes), lectures 
and review of 
exercise logs 
 
Baseline, 12 
weeks and 6 
months 
ICD/ACD 
N/A 
 
 
IC Time 
Group 1 
337% increase 
 
Group 2 
131% increase 
 
AC Time 
Group 1 
207% increase 
 
Group 2  
70% increase 
SF-36 (8 domains 
and 2 component 
scores) 
Physical Functioning, Bodily Pain and 
Physical Component scores improved for 
both groups at 12 weeks. Improvement 
unchanged at 6 months for both groups 
Baseline scores for Physical Functioning 
and General Health were significantly 
depressed for both groups compared with 
patients without chronic conditions 
 
Physical Functioning* 
Group 1  
Pre: 43 +/-17.7;  post :52 +/-22.2 
21% increase 
6 months: 56 +/-14.4 
30% increase from baseline  
Group 2:  
Pre:  41 +/-20.8:  53 +/-24.4 
29% increase 
6 months: 54 +/-23.5 
32% increase from baseline 
 
Bodily Pain*  
Group 1:  
Pre: 53 +/-20.8;  post: 64 +/- 23.6 
21% increase 
6 months: 62 +/-20.6 
17% increase from baseline 
 
No control group 
 
47 patients completed 12 week 
programme, 46 available for 
testing at 12 weeks and 38 
available at 6 months 
 
Compliance N/A 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
Group 2:  
Pre: 51 +/-20.6; post 61 +/-21.6 
20% increase 
6 months: 64 +/-19.3 
26% increase from baseline 
 
Physical Component Score* 
Group 1:  
Pre: 35 +/-7.1; post: 38 +/-8.3 
9% increase 
6 months: 39 +/-8.6 
11% increase from baseline  
Group 2: 33 +/-9.4; post: 38 +/-12 
15% increase 
6 months: 38 +/-11.1 
15% increase from baseline 
 
*mean (SD) 
Regen-
steiner et 
al 1997 
[22] 
Group 1 
Supervised 
exercise (10) 
 
 
 
 
Group 2 
Home exercise 
(10) 
Group 1 
Treadmill 
walking  
3 x 50 
minutes/week x 
12 weeks 
 
Group 2 
Instructed to 
walk x 3/week, 
weekly telephone 
call and exercise 
log 
 
Baseline and 
12 weeks 
ICD/ACD 
N/A 
 
IC Time 
Group 1 
150% increase 
Group 2 
26% increase 
 
AC Time 
Group 1 
137% increase 
Group 2 
5% increase 
SF-20 
(5 domains, 
Physical ,Social 
and Role 
Functioning, Well-
being and Overall 
Health) 
 
Significant improvement in Physical 
Functioning score (p<0.05) in supervised 
exercise group.  No change in any score 
in home exercise group. 
 
Supervised exercise group score: 
Physical Functioning* 
Pre: 52 +/-19; post:  72 +/-18 
39% increase 
 
*mean (SD) 
No control group 
Compliance 100% both groups 
Quantity of exercise  similar in 
both groups but the intensity in 
home group may have been 
lower 
Regen-
steiner et 
al 1996 
[15] 
Baseline 
Treadmill (10) 
Strength  (9) 
Control (10) 
 
Group 1 
Treadmill 
Supervised 
treadmill walking 
1 hour /day x 
Baseline, 12 
weeks, 24 
weeks 
ICD/ACD 
N/A 
 
AC Time  
Group 1 
SF-20 
(5 domains, 
Physical ,Social 
and Role 
Functioning, Well-
Treadmill group: 
Increase in Physical Functioning  score 
(p<0.05) after 12 weeks and remained 
increased after 24 weeks of training.  No 
change in other domains 
Compliance N/A 
 
 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
 
 
 
12 weeks  
Treadmill (10) 
Strength  (9) 
Control (8) 
 
 
 
 
24 weeks 
Treadmill (9) 
Strength + 
treadmill (6) 
Control + 
Strength + 
Treadmill  (6) 
 
 
 
3/week x 24 
weeks 
 
Group 2 
Strength 
Supervised 
strength training 
1 hour/day x 
3/week x 12 
weeks followed 
by  
treadmill 1 hour 
/day x 3/week x 
12 weeks 
 
Group 3 
Control 
Control x 12 
weeks followed 
by  
treadmill + 
strength training 
x 3/week x 12 
weeks  
12 weeks: 74% 
increase 
24 weeks: 
additional 49% 
increase 
 
Group 2 
12 weeks: 30% 
increase 
24 weeks: 
additional 54% 
increase 
 
Group 3 
12 weeks: No 
change 
24 weeks: 99% 
increase from 12 
weeks 
 
 
being and Overall 
Health) 
 
 
Physical Functioning* 
Pre: 42 +/-22;  12 weeks: +24 (9 to39) 
weeks); 24 weeks: + 38 (9 to 47) 
 
Weeks 12 and 24 = changes from 
baseline 
 
Strength group: 
Increase in Well-being scores after 12 
weeks but no improvement in other 
scores 
Well-being* 
Pre: 81 (+/-10);  12 weeks: +9 (2 to 16); 
24 weeks: +6 (-4 to 15) 
 
Weeks 12 and 24 = changes from 
baseline 
 
Control:  
No change in scores 
 
 
 * mean (SD) 
 
 
Currie et 
al  1995 
[29] 
Vascular 
operation (34) 
 
Angioplasty 
(74) 
 
Exercise (78) 
 
 
 
 
 
Unsupervised 
home exercise 
daily x 12 weeks 
based on exercise 
programme 
designed by 
physiotherapy 
 
 
 
 
Baseline and  
12 weeks 
ICD/ACD  
N/A 
 
IC/AC Time  
N/A 
SF-36 (8 domains) Exercise group  
Little change in QoL, slight improvement 
in Bodily Pain score 
 Compliance N/A 
 
No control group 
Table 1: Exercise intervention studies for patients with intermittent claudication (1989-2008): summary of studies assessing quality of 
life 
ICD, Initial claudication distance; ACD, Absolute claudication distance; EQ-5D,EuroQoL-5D; SF-36,Medical Outcomes Study 36-Item Short Form Health Survey; Fontaine 
Stage I (asymptomatic): Fontaine Stage II (intermittent claudication): Fontaine Stage III (rest pain); PLC, Profil der Lebensqualitat Chronisch Kranker questionnaire; PAVK-
86, Peripheral Arterial Occlusive Disease 86;VascuQoL, Vascular Quality of Life Survey; ICQ, Intermittent Claudication Questionnaire; CCQ, Charing Cross Claudication 
Questionnaire; Sickness Impact ProfileIC, Sickness Impact Profile Intermittent Claudication Scale 
a Reported as presented in paper (in some cases this is the number recruited, in some the number completing the study) 
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Study      No of 
participantsa 
Exercise 
Intervention 
Time of 
Outcome 
Measurement 
ICD/ACD  
changes following 
exercise (metres) 
QoL measure                     QoL findings 
 
Additional Comments 
department 
 
 
 
